Asparaginase‐associated pancreatitis in children
- 22 August 2012
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 159 (1) , 18-27
Abstract
Summary: l‐asparaginase has been an element in the treatment for acute lymphoblastic leukaemia (ALL) and non‐Hodgkin lymphoma since the late 1960s and remains an essential component of their combination chemotherapy. Among the major toxicities associated with l‐asparaginase therapy are pancreatitis, allergic reactions, thrombotic events, hepatotoxicity and hyperlipidaemia. Acute pancreatitis is one of the most common reasons for stopping treatment with l‐asparaginase. Short‐term complications of asparaginase‐associated pancreatitis include development of pseudocysts and pancreatic necrosis. Long‐term complications include chronic pancreatitis and diabetes. The pathophysiology of asparaginase‐associated pancreatitis remains to be uncovered. Individual clinical and genetic risk factors have been identified, but they are only weak predictors of pancreatitis. This review explores the definition, possible risk factors, treatment and complications of asparaginase‐associated pancreatitis.Keywords
This publication has 88 references indexed in Scilit:
- Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemiaLeukemia, 2012
- What Have We Learned About Acute Pancreatitis in Children?Journal of Pediatric Gastroenterology and Nutrition, 2011
- Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemiaBlood, 2010
- The Acinar Cell and Early Pancreatitis ResponsesClinical Gastroenterology and Hepatology, 2009
- Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase‐associated pancreatitisPediatric Blood & Cancer, 2009
- Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitisNature Genetics, 2007
- Early Antibiotic Treatment for Severe Acute Necrotizing PancreatitisAnnals of Surgery, 2007
- Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginaseJournal of Clinical Investigation, 2007
- Pharmacokinetic/Pharmacodynamic Relationships of Asparaginase FormulationsClinical Pharmacokinetics, 2005
- Acute pancreatitis in childhoodThe Journal of Pediatrics, 1988